US$ 26.06
boehringer glp 1 Weight loss drugs: Ingelheim, Terns, Viking may join market glp 1 boehringer GLP-1 Competitive
Description
Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])

Join our upcoming webinar to discover how advanced LC-MS workflows are transforming GLP-1 peptide characterization

Weight loss drugs can cost thousands per year without insurance

Chest pain is likely to be unrelated to the heart if it's brief, localized, trigger...

Features & Benefits
Hear from a doctor about how GLP-1s affect your health.
